Enhancing Functional Outcomes in Schizophrenia:Pharmacologic and Nonpharmacologic Strategies
A CME-Certified Initiative
On-Demand Web ActivityOctober 2008 to October 31, 2009
Earn up to an additional 2 AMA PRA Category 1 CreditsTM by completing this interactive, on-demand Web activity. Listen to commentary from experts John Kane, MD, Peter Buckley, MD and Philip Harvey, PhD, as they discuss the latest treatment strategies for patients with schizophrenia.
Click here to participate now!
On-Demand MonographJune 2008 to June 30, 2009
Earn up to 2 AMA PRA Category 1 CreditsTM by participating in this interactive, on-demand monograph, edited by John Kane, MD and reviewed by Richard Keefe, PhD. Learn how to better recognize cognitive impairments in your patients with schizophrenia and to identify the impact of these impairments on patient functioning. Raise your awareness of pharmacologic and nonpharmacologic interventions to address cognitive impairments in your patients.
Click here to participate now!
Live Workshops
Join us in Huntington Beach, California; New York, New York; and Rosemont, Illinois to earn up to 3 AMA PRA Category 1 CreditsTM for learning how to recognize and identify cognitive impairments, select pharmacologic and nonpharmacologic interventions that are appropriate for your patients, and consider the use of assessment tools to help you gauge your patients’ cognitive deficits.
Click here to register for the Scottsdale, Arizona meeting on Saturday, December 6, 2008
Clinical Tools
Click here for
a list of clinical tools you can use in your own practice to help you assess cognitive
impairment in your patients with schizophrenia.
Sponsored by Veritas Intitute for Medical Education, Inc.
Supported by an educational grant from Janssen, administered by Ortho-McNeil Jansen Scientific Affairs, LLC.